rxstat › Classes › Angiotensin Ii Antagonists, Plain

Angiotensin Ii Antagonists, Plain: shortage status in Canada

6 of the 7 angiotensin ii antagonists, plain rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Partial shortageCandesartan Cilexetil20 of 59 reported products affected · est. return Dec 31, 2020 Partial shortageIrbesartan10 of 43 reported products affected · est. return Dec 30, 2022 Partial shortageLosartan16 of 45 reported products affected · est. return Dec 31, 2026 Partial shortageOlmesartan Medoxomil2 of 24 reported products affected Partial shortageTelmisartan3 of 26 reported products affected Partial shortageValsartan3 of 43 reported products affected · est. return Jun 19, 2026 No current shortageAzilsartan Medoxomil

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.